515 MADISON AVE., SUITE 8133, NEW YORK, NY
News, Letter Re Change in Certifying Accountant
Announces Delisting, Termination of Business Combination Agreement with Regentis Biomaterials Ltd. and Subsequent Liquidation
Receives Failure to Satisfy a Continued Listing Rule from Nasdaq
Other Events
Submission of Matters to a Vote of Security Holders
Q1
Notice of Late Filing for Quarterly Report
FY 2023
Notice of Late Filing for Annual Report
Q3
Q2
Notice of Suspension of Duty to File Reports
Prospectus Filed Pursuant to Rule 425
RW
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Notification Filed by a National Security Exchange
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload